Notable
FDA
FDA Seeks Comment on Electronic Records and Signatures Collection Under PRA
FDA invites public comment on its proposed information collection for electronic record and signature provisions under 21 CFR Part 11, with implications for compliance and system design. The Food and Drug Administration (FDA) has issued a notice in the Federal Register requesting public comment...
The deep analysis — cross-item commentary and how this topic has evolved — is part of SignalHealth Pro.
Start a 14-day Pro trial — $9/monthSources — verify every claim